Exact Mass: 363.1834

Exact Mass Matches: 363.1834

Found 472 metabolites which its exact mass value is equals to given mass value 363.1834, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

ACMC-20lx5r

N-[L-5-Amino-5-carboxypentanoyl]-L-cysteinyl-D-valine

C14H25N3O6S (363.1464)

Dioncophylline C

C23H25NO3 (363.1834)

An isoquinoline alkaloid that is the biaryl resulting from substitution of the hydrogen at the 5-position of (1R,3R)-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-8-ol by a 5-hydroxy-4-methoxy-2-methylnaphthalen-1-yl group. It is a naphthylisoquinoline alkaloid isolated from the roots and stem barks of Triphyophyllum peltatum and exhibits antimalarial activity.

6-(1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopropyl)nicotinic acid

6-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopropyl]pyridine-3-carboxylic acid

C24H29NO2 (363.2198)

Methixene hydrochloride

Metixene hydrochloride hydrate

C20H26ClNOS (363.1424)

C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent

Leg5Ac7Ala

C14H25N3O8 (363.1642)

Murrayanol

1-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-7-methoxy-6-methyl-9H-carbazol-2-ol

C24H29NO2 (363.2198)

Murrayanol is found in herbs and spices. Murrayanol is an alkaloid from seeds of Murraya koenigii (curry leaf tree). Alkaloid from seeds of Murraya koenigii (curry leaf tree). Murrayanol is found in herbs and spices.

8-Methyldihydrochelerythrine

17,18-dimethoxy-20,21-dimethyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14(19),15,17-octaene

C22H21NO4 (363.1471)

8-Methyldihydrochelerythrine is found in fruits. 8-Methyldihydrochelerythrine is an alkaloid from root bark of Zanthoxylum simulans (Szechuan pepper). Alkaloid from root bark of Zanthoxylum simulans (Szechuan pepper). 8-Methyldihydrochelerythrine is found in herbs and spices and fruits.

2-(1-(5-Fluoropentyl)-1H-indazole-3-ylcarbonylamino)-3-methylbutanoic acid methyl ester

C19H26FN3O3 (363.1958)

6-Hydroxyindoramin

N-{1-[2-(6-hydroxy-1H-indol-3-yl)ethyl]piperidin-4-yl}benzamide

C22H25N3O2 (363.1947)

Bucindolol

2-(2-hydroxy-3-{[1-(1H-indol-3-yl)-2-methylpropan-2-yl]amino}propoxy)benzonitrile

C22H25N3O2 (363.1947)

C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Bucindolol is a β1-adrenergic receptor blocker, with intrinsic sympathomimetic activity, used in the research of heart failure[1].

(2S)-1-[(2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoyl]pyrrolidine-2-carboxylic acid

C16H21N5O5 (363.1543)

Dioncophylline C

5-(5-hydroxy-4-methoxy-2-methylnaphthalen-1-yl)-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-8-ol

C23H25NO3 (363.1834)

N-((Tetrahydro-5-oxo-2-furanyl)carbonyl)-L-histidyl-L-prolinamide

1-[3-(1H-imidazol-5-yl)-2-[(5-oxooxolane-2-carbonyl)amino]propanoyl]pyrrolidine-2-carboxamide

C16H21N5O5 (363.1543)

6-[1-(3,5,5,8,8-Pentamethyl-6,7-dihydronaphthalen-2-yl)cyclopropyl]pyridine-2-carboxylic acid

6-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopropyl]pyridine-2-carboxylic acid

C24H29NO2 (363.2198)

Libenzapril

6-amino-2-{[1-(carboxymethyl)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-3-yl]amino}hexanoic acid

C18H25N3O5 (363.1794)

2-[[[4-(3-Benzylcyclobutyl)-1,3-thiazol-2-yl]diazenyl]methyl]phenol

2-({2-[4-(3-benzylcyclobutyl)-1,3-thiazol-2-yl]diazen-1-yl}methyl)phenol

C21H21N3OS (363.1405)

Pglu-his-pro

1-(2-{[hydroxy(5-hydroxy-3,4-dihydro-2H-pyrrol-2-yl)methylidene]amino}-3-(1H-imidazol-5-yl)propanoyl)pyrrolidine-2-carboxylate

C16H21N5O5 (363.1543)

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones Thyrotropin-Releasing Hormone (TRH), Free Acid (TRH-OH) is a physiological metabolite of Thyrotropin-Releasing Hormone.

Thiencynonate

3-Methyl-3-azabicyclo[3.3.1]nonan-9-yl 2-cyclopentyl-2-hydroxy-2-(thiophen-2-yl)acetic acid

C20H29NO3S (363.1868)

N-((2,2-Dimethyl-2,3-dihydro-benzofuran-7-yloxy)ethyl)-3-(cyclopent-1-enyl)benzylamine

{[3-(cyclopent-1-en-1-yl)phenyl]methyl}({2-[(2,2-dimethyl-2,3-dihydro-1-benzofuran-7-yl)oxy]ethyl})amine

C24H29NO2 (363.2198)

D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists

antofine

InChI=1/C23H25NO3/c1-25-15-6-7-16-18(10-15)20-12-23(27-3)22(26-2)11-19(20)17-9-14-5-4-8-24(14)13-21(16)17/h6-7,10-12,14H,4-5,8-9,13H2,1-3H3/t14-/m1/s

C23H25NO3 (363.1834)

(-)-antofine is an organic heteropentacyclic compound that is (13aR)-9,11,12,13,13a,14-hexahydrodibenzo[f,h]pyrrolo[1,2-b]isoquinoline substituted at positions 2, 3 and 6 by methoxy groups. It is an alkaloid produced by relatives of the milkweed family and exhibits antiviral, anti-inflammatory, antiadipogenic and antitumorigenic activities. It has a role as an antineoplastic agent, a plant metabolite, a phytotoxin, an antimicrobial agent, an anti-inflammatory agent, an antiviral agent and an angiogenesis inhibitor. It is an organic heteropentacyclic compound, an aromatic ether, an alkaloid and an alkaloid antibiotic. (13aR)-2,3,6-trimethoxy-9,11,12,13,13a,14-hexahydrophenanthro[9,10-f]indolizine is a natural product found in Ficus septica, Vincetoxicum paniculatum, and other organisms with data available. An organic heteropentacyclic compound that is (13aR)-9,11,12,13,13a,14-hexahydrodibenzo[f,h]pyrrolo[1,2-b]isoquinoline substituted at positions 2, 3 and 6 by methoxy groups. It is an alkaloid produced by relatives of the milkweed family and exhibits antiviral, anti-inflammatory, antiadipogenic and antitumorigenic activities.

Euchrestine B

C24H29NO2 (363.2198)

Consiculine

C20H29NO5 (363.2046)

Amphorogynine C

C19H25NO6 (363.1682)

5-O-Demethyldioncophylline A

C23H25NO3 (363.1834)

Kealiinine B

C21H21N3O3 (363.1583)

(-)-Spirotriprostatin

C21H21N3O3 (363.1583)

Stephuline

C19H25NO6 (363.1682)

AUSTAMIDE

C21H21N3O3 (363.1583)

Buxifoliadine G

C22H21NO4 (363.1471)

Longaninine

C19H25NO6 (363.1682)

Dioncophyllin d

C23H25NO3 (363.1834)

Kahakamide B

C17H21N3O6 (363.143)

Dechlorodauricumine

C19H25NO6 (363.1682)

Opipramol

C23H29N3O (363.2311)

N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AA - Non-selective monoamine reuptake inhibitors D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators

N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-benzyl-1H-indole-3-carboxamide

C22H25N3O2 (363.1947)

4-Fluoro AMB

C19H26FN3O3 (363.1958)

5F-AMB

C19H26FN3O3 (363.1958)

ZINC13466751

C20H21N5O2 (363.1695)

Maybridge3_002446

C22H22FN3O (363.1747)

MMV688178

C24H17N3O (363.1372)

Almazole A

C21H21N3O3 (363.1583)

PGlu-3-methyl-His-Pro-NH2

C16H21N5O5 (363.1543)

1,3-dihydroxy-2,4-bis(3-methylbut-2-enyl)-9a,10-dihydro-4aH-acridin-9-one|1,3-dihydroxy-2,4-diprenylacridone|atalaphylline

C23H25NO3 (363.1834)

2,2-Bis(3-indolyl)indoxyl

C24H17N3O (363.1372)

spongiacysteine

C17H33NO5S (363.2079)

Deoxytylophorinine

C23H25NO3 (363.1834)

Antibiotic SF 2339

C14H25N3O8 (363.1642)

N-Methyl Mitomycin A

C17H21N3O6 (363.143)

2-[6-(1,3-Benzodioxole-5-yl)hexyl]-4-methoxyquinoline

C23H25NO3 (363.1834)

2alpha-hydroxylenticellarine

C19H25NO6 (363.1682)

(15E)-12beta-acetoxy-18-nor-senecionane-11,16-dione|Crotastriatin|crotastriatine|O-acetyl-nilgirine

C19H25NO6 (363.1682)

Dioncophyllin b

C23H25NO3 (363.1834)

Junenol|Saussureamine E

C20H29NO5 (363.2046)

3,7-dimethoxy-6-hydroxy-11,12,13,14,14a,15-hexahydro-9H-phenanthro[9,10-b]quinolizidine|Boehmeriasin B

C23H25NO3 (363.1834)

C18H25N3O5

C18H25N3O5 (363.1794)

Nauclechine

C21H21N3O3 (363.1583)

Lyadine

C21H21N3O3 (363.1583)

C22H25N3O2

C22H25N3O2 (363.1947)

alpha-Naucleonidine

C21H21N3O3 (363.1583)

C22H21NO4

C22H21NO4 (363.1471)

C19H25NO6

C19H25NO6 (363.1682)

(+)-miliusane V|8beta-acetylamino-9beta-hydroxy-1beta-(2,6-dimethylhepta-1,5-dienyl)-2-oxa-spiro[4.5]dec-7-ene-3,6-dione

C20H29NO5 (363.2046)

Nauclefoline +

C21H21N3O3 (363.1583)

xiamycin|xiamycin A

C23H25NO3 (363.1834)

crotavitelin

C19H25NO6 (363.1682)

O-Methylhernandine

C19H25NO6 (363.1682)

Nonylprodigiosin

C23H29N3O (363.2311)

3,3-Bis(1H-indole-3-yl)-2-indolinone

C24H17N3O (363.1372)

Alkaloid CG1

C22H21NO4 (363.1471)

(2E)-11-(4-aminophenyl)-5,9-dihydroxy-4,6,8-trimethyl-11-oxo-undec-2-enoic acid

C20H29NO5 (363.2046)

dioncophylline E

C23H25NO3 (363.1834)

Cadamine

C21H21N3O3 (363.1583)

(7E,9aS,11S,13S,13aS)-2,3,4,5,6,8,9,9a,10,11,12,13-dodecahydro-11-methyl-8-oxo-1H-indeno[1,7a-c]azonine-11,13-diyl diacetate|lycoposerramine-T

C20H29NO5 (363.2046)

CHEMBL2270127

C23H25NO3 (363.1834)

C23H25NO3

C23H25NO3 (363.1834)

Transvalencin Z

C17H21N3O6 (363.143)

Antibiotic RP 35391

C15H21N7O4 (363.1655)

Saussureamine D

C20H29NO5 (363.2046)

Ser Leu Met

C15H29N3O5S (363.1828)

Ala His His

C15H21N7O4 (363.1655)

Phe Ala Leu

C19H29N3O4 (363.2158)

Leu Phe Ala

C19H29N3O4 (363.2158)

Ser Met Leu

C15H29N3O5S (363.1828)

Thr Pro Phe

C18H25N3O5 (363.1794)

ACMC-20n6nc

C19H29N3O4 (363.2158)

Glu Cys Ile

C14H25N3O6S (363.1464)

Leu Ala Phe

C19H29N3O4 (363.2158)

Pro Phe Thr

C18H25N3O5 (363.1794)

Phe Leu Ala

C19H29N3O4 (363.2158)

Phe Pro Thr

C18H25N3O5 (363.1794)

Ala Phe Leu

C19H29N3O4 (363.2158)

Met Ser Leu

C15H29N3O5S (363.1828)

Asp Val Met

C14H25N3O6S (363.1464)

Met Asp Val

C14H25N3O6S (363.1464)

Ala Leu Phe

C19H29N3O4 (363.2158)

Ile Cys Glu

C14H25N3O6S (363.1464)

Phe Val Val

C19H29N3O4 (363.2158)

Lys Asn Cys

C13H25N5O5S (363.1576)

Ile Glu Cys

C14H25N3O6S (363.1464)

SCHEMBL18568242

C19H29N3O4 (363.2158)

His Ala His

C15H21N7O4 (363.1655)

Thr Met Ile

C15H29N3O5S (363.1828)

Met Leu Ser

C15H29N3O5S (363.1828)

Pro Thr Phe

C18H25N3O5 (363.1794)

Cys Lys Asn

C13H25N5O5S (363.1576)

Val Met Asp

C14H25N3O6S (363.1464)

Met Ile Thr

C15H29N3O5S (363.1828)

Asp Met Val

C14H25N3O6S (363.1464)

Met Thr Ile

C15H29N3O5S (363.1828)

Leu Met Ser

C15H29N3O5S (363.1828)

Leu Asp Cys

C14H25N3O6S (363.1464)

His His Ala

C15H21N7O4 (363.1655)

CAY10581

(±)3,4-dihydro-3-hydroxy-2,2-dimethyl-4-[(phenylmethyl)amino]-2H-naphtho[2,3-b]pyran-5,10-dione

C22H21NO4 (363.1471)

Murrayanol

C24H29NO2 (363.2198)

C21H21N3O3_8,8-Dimethyl-5a,6-dihydro-3H,5H,8H-spiro[indole-2,7-pyrrolo[1,2:4,5]pyrazino[1,2-a]azepine]-3,5,12(1H,2H)-trione

NCGC00380729-01_C21H21N3O3_8,8-Dimethyl-5a,6-dihydro-3H,5H,8H-spiro[indole-2,7-pyrrolo[1,2:4,5]pyrazino[1,2-a]azepine]-3,5,12(1H,2H)-trione

C21H21N3O3 (363.1583)

3,N4-4-Oxo-(2E)-nonenal-deoxycytidine

C18H25N3O5 (363.1794)

Cys Gly Gly Lys

(2S)-6-amino-2-(2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}acetamido)hexanoic acid

C13H25N5O5S (363.1576)

Cys Gly Lys Gly

2-[(2S)-6-amino-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}hexanamido]acetic acid

C13H25N5O5S (363.1576)

Cys Lys Gly Gly

2-{2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]acetamido}acetic acid

C13H25N5O5S (363.1576)

Gly Cys Gly Lys

(2S)-6-amino-2-{2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]acetamido}hexanoic acid

C13H25N5O5S (363.1576)

Gly Cys Lys Gly

2-[(2S)-6-amino-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]hexanamido]acetic acid

C13H25N5O5S (363.1576)

Gly Gly Cys Lys

(2S)-6-amino-2-[(2R)-2-[2-(2-aminoacetamido)acetamido]-3-sulfanylpropanamido]hexanoic acid

C13H25N5O5S (363.1576)

Gly Gly Lys Cys

(2R)-2-[(2S)-6-amino-2-[2-(2-aminoacetamido)acetamido]hexanamido]-3-sulfanylpropanoic acid

C13H25N5O5S (363.1576)

Gly Lys Cys Gly

2-[(2R)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-sulfanylpropanamido]acetic acid

C13H25N5O5S (363.1576)

Gly Lys Gly Cys

(2R)-2-{2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]acetamido}-3-sulfanylpropanoic acid

C13H25N5O5S (363.1576)

Gly Asn Ser Ser

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

C12H21N5O8 (363.139)

Gly Ser Asn Ser

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C12H21N5O8 (363.139)

Gly Ser Ser Asn

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C12H21N5O8 (363.139)

Thr Ile Met

C15H29N3O5S1 (363.1828)

Glu Ile Cys

C14H25N3O6S1 (363.1464)

Leu Glu Cys

C14H25N3O6S1 (363.1464)

Lys Cys Gly Gly

2-{2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]acetamido}acetic acid

C13H25N5O5S (363.1576)

Cys Asn Lys

C13H25N5O5S1 (363.1576)

Lys Gly Cys Gly

2-[(2R)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-sulfanylpropanamido]acetic acid

C13H25N5O5S (363.1576)

Lys Gly Gly Cys

(2R)-2-(2-{2-[(2S)-2,6-diaminohexanamido]acetamido}acetamido)-3-sulfanylpropanoic acid

C13H25N5O5S (363.1576)

Thr Met Ile

C15H29N3O5S1 (363.1828)

Glu Cys Leu

C14H25N3O6S1 (363.1464)

Asp Met Val

C14H25N3O6S1 (363.1464)

Cys Ile Glu

C14H25N3O6S1 (363.1464)

Leu Met Thr

C15H29N3O5S1 (363.1828)

Cys Glu Ile

C14H25N3O6S1 (363.1464)

Met Asp Val

C14H25N3O6S1 (363.1464)

Ile Cys Glu

C14H25N3O6S1 (363.1464)

Val Asp Met

C14H25N3O6S1 (363.1464)

Met Thr Ile

C15H29N3O5S1 (363.1828)

Glu Cys Ile

C14H25N3O6S1 (363.1464)

Asn Lys Cys

C13H25N5O5S1 (363.1576)

Thr Phe Pro

C18H25N3O5 (363.1794)

Met Val Asp

C14H25N3O6S1 (363.1464)

Asn Gly Ser Ser

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-hydroxypropanamido]-3-hydroxypropanoic acid

C12H21N5O8 (363.139)

Thr Met Leu

C15H29N3O5S1 (363.1828)

Ile Thr Met

C15H29N3O5S1 (363.1828)

Asn Ser Gly Ser

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]acetamido}-3-hydroxypropanoic acid

C12H21N5O8 (363.139)

Asn Ser Ser Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]acetic acid

C12H21N5O8 (363.139)

Ile Met Thr

C15H29N3O5S1 (363.1828)

Val Val Phe

C19H29N3O4 (363.2158)

Leu Cys Glu

C14H25N3O6S1 (363.1464)

Val Phe Val

C19H29N3O4 (363.2158)

Lys Cys Asn

C13H25N5O5S1 (363.1576)

Met Thr Leu

C15H29N3O5S1 (363.1828)

Asn Cys Lys

C13H25N5O5S1 (363.1576)

Val Met Asp

C14H25N3O6S1 (363.1464)

Thr Leu Met

C15H29N3O5S1 (363.1828)

Phe Thr Pro

C18H25N3O5 (363.1794)

Ile Glu Cys

C14H25N3O6S1 (363.1464)

Lys Asn Cys

C13H25N5O5S1 (363.1576)

Cys Leu Glu

C14H25N3O6S1 (363.1464)

Met Leu Thr

C15H29N3O5S1 (363.1828)

Glu Leu Cys

C14H25N3O6S1 (363.1464)

Ser Gly Asn Ser

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C12H21N5O8 (363.139)

Ser Gly Ser Asn

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C12H21N5O8 (363.139)

Ser Asn Gly Ser

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]acetamido}-3-hydroxypropanoic acid

C12H21N5O8 (363.139)

Cys Lys Asn

C13H25N5O5S1 (363.1576)

Ser Asn Ser Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]acetic acid

C12H21N5O8 (363.139)

Asp Val Met

C14H25N3O6S1 (363.1464)

Cys Glu Leu

C14H25N3O6S1 (363.1464)

Met Ile Thr

C15H29N3O5S1 (363.1828)

Ser Ser Gly Asn

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]acetamido}-3-carbamoylpropanoic acid

C12H21N5O8 (363.139)

Ser Ser Asn Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]acetic acid

C12H21N5O8 (363.139)

Leu Thr Met

C15H29N3O5S1 (363.1828)

Coralyne

C22H21NO4 (363.1471)

Isopentenyladenine-9-N-glucoside

C17H25N5O4 (363.1906)

6-Hydroxyindoramin

C22H25N3O2 (363.1947)

8-Methyldihydrochelerythrine

17,18-dimethoxy-20,21-dimethyl-5,7-dioxa-21-azapentacyclo[11.8.0.0^{2,10}.0^{4,8}.0^{14,19}]henicosa-1(13),2,4(8),9,11,14,16,18-octaene

C22H21NO4 (363.1471)

Dizatrifone

C21H21N3O3 (363.1583)

1-N-Boc-4-(2-Ncbzaminoethyl)piperazine

C19H29N3O4 (363.2158)

Ethyl 5-amino-2-methyl-4-phenyl-1,4,6,7,8,9-hexahydrobenzo[b][1,8 ]naphthyridine-3-carboxylate

C22H25N3O2 (363.1947)

AMINO-(3,4-DIBENZYLOXY-PHENYL)-ACETIC ACID

C22H21NO4 (363.1471)

2-(METHYLSULFANYL)[1,3]OXAZOLO[4,5-B]PYRIDINE

C22H21NO4 (363.1471)

dimethyl-bis(prop-2-enyl)azanium,2-hydroxypropyl prop-2-enoate,prop-2-enoic acid,chloride

C17H30ClNO5 (363.1812)

1-FMOC-4-CARBOXYMETHYLENE-PIPERIDINE

C22H21NO4 (363.1471)

6-(4-(4-CYANOPHENYL)PHENOXY)HEXYL METHA&

C23H25NO3 (363.1834)

3-HYDROXY-2,3-DIMETHYLBUTAN-2-YL HYDROGEN (3-((1,3-DIOXOISOINDOLIN-2-YL)METHYL)PHENYL)BORONATE

C21H22BNO4 (363.1642)

benzyl 2-amino-5-methoxy-4-phenylmethoxybenzoate

C22H21NO4 (363.1471)

(2-PHTALIMIDOMETHYLPHENYL)BORONIC ACID, PINACOL ESTER

C21H22BNO4 (363.1642)

Urea, N-[2-[(3-cyano-8-methyl-2-quinolinyl)amino]ethyl]-N-(4-fluorophenyl)- (9CI)

C20H18FN5O (363.1495)

Urea, N-[2-[(3-cyano-8-methyl-2-quinolinyl)amino]ethyl]-N-(2-fluorophenyl)- (9CI)

C20H18FN5O (363.1495)

[2-(dimethylamino)-2-methylpropyl] 2-hydroxy-2,2-diphenylacetate,hydrochloride

C20H26ClNO3 (363.1601)

Necopidem

C23H29N3O (363.2311)

(4-PHTHALIMIDOMETHYLPHENYL)BORONIC ACID, PINACOL ESTER

C21H22BNO4 (363.1642)

[4-(Carbazol-9-yl)-1,1-biphenyl-4-yl]boronic acid

C24H18BNO2 (363.1431)

carocainide

C18H25N3O5 (363.1794)

1-CBZ-4-(2-N-BOC-AMINO-ETHYL)-PIPERAZINE

C19H29N3O4 (363.2158)

(6,9-Diphenyl-9H-carbazol-3-yl)boronic acid

C24H18BNO2 (363.1431)

1-Benzyl-4-[(5,6-dimethoxy-1H-inden-2-yl)methyl]piperidine

C24H29NO2 (363.2198)

Efaproxiral sodium

C20H22NNaO4 (363.1446)

C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent

3-{5-[(2R)-2-Aminopropyl]-7-cyano-2,3-dihydro-1H-indol-1-yl}propy l benzoate

C22H25N3O2 (363.1947)

erythro-N-[(Phenylmethoxy)carbonyl]-3-allyl-L-aspartic acid 1-tert-butyl ester

C19H25NO6 (363.1682)

1-(2-CHLORO-PHENYL)-PROP-2-YN-1-OL

C20H21N5O2 (363.1695)

n-methoxy-n-methyl(triphenyl-phosphoranylidene)acetamide

C22H22NO2P (363.1388)

Tris(methylethylketoxime)phenylsilane

C18H29N3O3Si (363.1978)

pyridine, 1-oxide-4-ethenyl-, homopolymer

C21H21N3O3 (363.1583)

Pirolazamide

C23H29N3O (363.2311)

C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

1-[2-(4-(Trifluoromethyl)phenyl)ethyl]-6,7-dimethoxy-3,4-dihydroisoquinoline

C20H20F3NO2 (363.1446)

((1R,2R)-2-AMINO-CYCLOHEXYL)-METHANOL

C20H27F2N3O (363.2122)

Libenzapril

C18H25N3O5 (363.1794)

D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

Ozenoxacin

C21H21N3O3 (363.1583)

D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D004791 - Enzyme Inhibitors

4-Boc-7-Bocamino-3,4-dihydroquinoxalin-2-one

C18H25N3O5 (363.1794)

Thiphenamil hydrochloride

S-[2-(diethylamino)ethyl] alpha-phenylbenzeneethanethioate hydrochloride

C20H26ClNOS (363.1424)

C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent

antazoline

Antazoline phosphate

C17H22N3O4P (363.1348)

D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents

4-ethenoxybutyl N-(3-triethoxysilylpropyl)carbamate

C16H33NO6Si (363.2077)

1-Morpholino-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)propan-2-ol

C19H30BNO5 (363.2217)

7-Amino-6-phenoxy-3-[(tetrahydrofuran-2-yl)methyl]quinazolin-4(3H)-one

C22H25N3O2 (363.1947)

9-(4-Biphenylyl)-3-boronic acid

C24H18BNO2 (363.1431)

Isopropyl 4-{5-[bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoate

C19H29N3O4 (363.2158)

tert-butyl 3-{[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}azetidine-1-carboxylate

C18H30BN3O4 (363.2329)

9-(Biphenyl-4-yl)carbazole-2-boronic acid

C24H18BNO2 (363.1431)

(15E)-12β-Acetoxy-18-norsenecionan-11,16-dione

C19H25NO6 (363.1682)

4-(tert-Butyldiphenylsilyloxy)cyclohexanecarbonitrile

C23H29NOSi (363.2018)

5-(2-Aminopropyl)-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile

C22H25N3O2 (363.1947)

4-(2-[2-METHOXY-4-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-PHENOXY]-ETHYL)-MORPHOLINE

C19H30BNO5 (363.2217)

GLY-PRO 4-METHOXY-BETA-NAPHTHYLAMIDE HYDROCHLORIDE

C18H22ClN3O3 (363.135)

adafenoxate

C20H26ClNO3 (363.1601)

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tosyl-1,2,3,6-tetrahydropyridine

C18H26BNO4S (363.1676)

1-Benzyl-4-(5,6-dimethoxy-1H-2-indenylmethyl)piperidine

C24H29NO2 (363.2198)

8-DeMethoxy-8-fluoro Gatifloxacin

C18H19F2N3O3 (363.1394)

Benactyzine hydrochloride

C20H26ClNO3 (363.1601)

l-d-(a-Aminoadipoyl)-l-cysteinyl-d-valine

C14H25N3O6S (363.1464)

N-((1-(5-Fluoropentyl)-1H-indazol-3-yl)carbonyl)valine methyl ester

C19H26FN3O3 (363.1958)

Dioncophylline B

C23H25NO3 (363.1834)

A natural product found in Triphyophyllum peltatum.

Sepantronium

C20H19N4O3+ (363.1457)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor

2-[4-(1-adamantyl)-N-methylsulfonylanilino]acetic acid

C19H25NO4S (363.1504)

Protuboxepin B

C21H21N3O3 (363.1583)

An organic heterotricyclic compound that is 10,11-dihydro-6H-oxepino[2,3-d]pyrazino[1,2-a]pyrimidine-6,9(8H)-dione substituted by a benzyl group at position 8 and an isopropyl group at position 11. It has been isolated from Aspergillus species.

2-[(4-amino-5-cyclohexyl-1,2,4-triazol-3-yl)thio]-N-(3-fluoro-4-methylphenyl)acetamide

C17H22FN5OS (363.1529)

D-Galactitol, 2-(acetylmethylamino)-2-deoxy-3,4,6-tri-O-methyl-, 1,5-diacetate

C16H29NO8 (363.1893)

19-(Cyclopropylamino)-4,6,7,15-Tetrahydro-5h-16,1-(Azenometheno)-10,14-(Metheno)pyrazolo[4,3-O][1,3,9]triazacyclohexadecin-8(9h)-One

C19H21N7O (363.1807)

(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime

C20H18FN5O (363.1495)

5-[6-(4-phenoxyphenyl)pyrazin-2-yl]-1H-indole

C24H17N3O (363.1372)

(2S)-1-[(2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoyl]pyrrolidine-2-carboxylic acid

C16H21N5O5 (363.1543)

3-[[(E)-4-Methoxy-4-oxo-2-butenoyl]amino]-L-Ala-L-Phe-OH

C17H21N3O6 (363.143)

(1R,2R,5S,8S,9S,10R,11R,12R,13S)-5,12,13-trihydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate

C19H23O7- (363.1444)

N-acetyl-alpha-D-muramoyl-L-alaninate

C14H23N2O9- (363.1403)

The carbohydrate acid derivative anion formed by loss of a proton from the carboxy group of N-acetyl-alpha-D-muramoyl-L-alanine; principal microspecies at pH 7.3.

3-{[(2E)-4-methoxy-4-oxobut-2-enoyl]amino}alanyl-L-phenylalanine

C17H21N3O6 (363.143)

5-[6-(Cyclohexylamino)-9-purinyl]-2-(hydroxymethyl)-4-methoxy-3-oxolanol

C17H25N5O4 (363.1906)

gibberellin A8(1-)

C19H23O7- (363.1444)

Conjugate base of gibberellin A8.

6-(1,3-benzodioxol-5-yl)-N-(3-oxanylmethyl)-4-quinazolinamine

C21H21N3O3 (363.1583)

2-[4-(2-methylpropyl)phenyl]propanoic acid [2-(1H-indol-3-yl)-2-oxoethyl] ester

C23H25NO3 (363.1834)

(9S,11R)-12,12-dimethylspiro[1,7-diazatricyclo[7.5.0.03,7]tetradeca-3,13-diene-11,2-1H-indole]-2,3,8-trione

C21H21N3O3 (363.1583)

N-ethyl-N-(2-ethylphenyl)-3-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]propanamide

C22H25N3O2 (363.1947)

Ala-His-His

C15H21N7O4 (363.1655)

Val-Phe-Val

C19H29N3O4 (363.2158)

phe-FMDP

C17H21N3O6 (363.143)

A dipeptide composed of 3-{[(2E)-4-methoxy-4-oxobut-2-enoyl]amino}alanine and L-phenylalanine joined by peptide linkages.

2,4,5-trimethoxy-N-(2-phenylphenyl)benzamide

C22H21NO4 (363.1471)

N-[1-(2,3-dimethylphenyl)-4,5,6,7-tetrahydroindazol-4-yl]-2,5-dimethyl-3-pyrazolecarboxamide

C21H25N5O (363.2059)

2-[[2-[1-(2-methoxyethyl)-2,5-dimethyl-3-pyrrolyl]-2-oxoethyl]thio]-6-propyl-1H-pyrimidin-4-one

C18H25N3O3S (363.1617)

N-[1-(3,4-dimethylphenyl)-4,5,6,7-tetrahydroindazol-4-yl]-2,5-dimethyl-3-pyrazolecarboxamide

C21H25N5O (363.2059)

1-(4-Fluorophenyl)-1-cyclopentanecarboxylic acid [2-(2,6-dimethyl-4-morpholinyl)-2-oxoethyl] ester

C20H26FNO4 (363.1846)

6-fluoro-2-phenyl-N-(3-(piperidin-1-yl)propyl)quinolin-4-amine

C23H26FN3 (363.2111)

5-[(3-Phenylmethoxy-1-piperidinyl)methyl]-3-(phenylmethyl)-1,2,4-oxadiazole

C22H25N3O2 (363.1947)

1-(1,3-benzoxazol-2-yl)-N-[(4-ethylphenyl)methyl]-3-piperidinecarboxamide

C22H25N3O2 (363.1947)

(5Z)-4-methoxy-3-methyl-5-[(1R,9R,10R,11R,12S)-12-methyl-5-oxido-14,15-dioxa-5-azoniatetracyclo[7.5.1.01,11.05,10]pentadecan-13-ylidene]furan-2-one

C19H25NO6 (363.1682)

1-(4,6-dimethoxy-1,3,5-triazin-2-yl)-N-(thiophen-2-ylmethyl)-4-piperidinecarboxamide

C16H21N5O3S (363.1365)

3-[[4-[(4-chlorophenyl)methyl]-4-(hydroxymethyl)-1-piperidinyl]-oxomethyl]-4,5-dihydro-1H-pyridazin-6-one

C18H22ClN3O3 (363.135)

N-[(E)-(5-Morpholin-4-ylthiophen-2-yl)methylideneamino]-N-phenylaniline

C21H21N3OS (363.1405)

3-methyl-2-[[2-(methylamino)-1-oxopropyl]amino]-N-[1-oxo-1-(phenylhydrazo)propan-2-yl]butanamide

C18H29N5O3 (363.227)

N-[[(2S)-3beta-(Ethoxycarbonyl)aziridine-2alpha-yl]carbonyl]-Gly-Gly-OBzl

C17H21N3O6 (363.143)

6-(1,3-benzodioxol-5-yl)-N-(2-oxanylmethyl)-4-quinazolinamine

C21H21N3O3 (363.1583)

1-Tetradecanoyl-sn-glycero-2,3-cyclic phosphate

C17H32O6P- (363.1936)

2-[(3R,4S)-3-[[5-(methoxymethyl)-1,2-oxazol-3-yl]methyl]piperidin-4-yl]-N-(thiophen-2-ylmethyl)acetamide

C18H25N3O3S (363.1617)

Met-Val-Asp

C14H25N3O6S (363.1464)

Thr-Pro-Phe

C18H25N3O5 (363.1794)

His-Ala-His

C15H21N7O4 (363.1655)

Met-Asp-Val

C14H25N3O6S (363.1464)

Thr-Phe-Pro

C18H25N3O5 (363.1794)

N-acetyl-D-muramoyl-L-alaninate

C14H23N2O9- (363.1403)

hydron;1-methyl-3-(9H-thioxanthen-9-ylmethyl)piperidine;chloride;hydrate

C20H26ClNOS (363.1424)

N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3-oxanyl]-2-pyridinecarboxamide

C18H25N3O5 (363.1794)

2-[(3S,6aR,8R,10aR)-3-hydroxy-1-(pyridin-4-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide

C19H29N3O4 (363.2158)

3-(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)-N-(3,4-dihydro-2H-pyrrol-5-yl)benzamide

C19H21N7O (363.1807)

N-[(2R,3S,6S)-2-(hydroxymethyl)-6-(2-morpholin-4-yl-2-oxoethyl)oxan-3-yl]pyridine-2-carboxamide

C18H25N3O5 (363.1794)

N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3-oxanyl]-2-pyridinecarboxamide

C18H25N3O5 (363.1794)

2-[(3S,6aS,8R,10aS)-3-hydroxy-1-(pyridin-4-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide

C19H29N3O4 (363.2158)

2-[(3R,6aR,8R,10aR)-3-hydroxy-1-(pyridin-4-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide

C19H29N3O4 (363.2158)

2-[(3R,6aS,8S,10aS)-3-hydroxy-1-(pyridin-4-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide

C19H29N3O4 (363.2158)

2-[(3S,6aS,8S,10aS)-3-hydroxy-1-(pyridin-4-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide

C19H29N3O4 (363.2158)

N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C19H29N3O4 (363.2158)

N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C19H29N3O4 (363.2158)

N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C19H29N3O4 (363.2158)

N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C19H29N3O4 (363.2158)

N-[(5R,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C19H29N3O4 (363.2158)

N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3-oxanyl]-2-pyridinecarboxamide

C18H25N3O5 (363.1794)

2-[(3R,6aR,8S,10aR)-3-hydroxy-1-(pyridin-4-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide

C19H29N3O4 (363.2158)

2-[(3R,6aS,8R,10aS)-3-hydroxy-1-(pyridin-4-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide

C19H29N3O4 (363.2158)

4-oxanyl-[(1R,5S)-7-(4-pyridin-4-ylphenyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl]methanone

C22H25N3O2 (363.1947)

[(1-amino-2-naphthalen-1-ylethylidene)amino] N-(2-ethoxyphenyl)carbamate

C21H21N3O3 (363.1583)

N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C19H29N3O4 (363.2158)

N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C19H29N3O4 (363.2158)

N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C19H29N3O4 (363.2158)

N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C19H29N3O4 (363.2158)

N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C19H29N3O4 (363.2158)

N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C19H29N3O4 (363.2158)

N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C19H29N3O4 (363.2158)

N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3-oxanyl]-2-pyridinecarboxamide

C18H25N3O5 (363.1794)

N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3-oxanyl]-2-pyridinecarboxamide

C18H25N3O5 (363.1794)

N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3-oxanyl]-2-pyridinecarboxamide

C18H25N3O5 (363.1794)

N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3-oxanyl]-2-pyridinecarboxamide

C18H25N3O5 (363.1794)

2-[(3S,6aR,8S,10aR)-3-hydroxy-1-(pyridin-4-ylmethyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide

C19H29N3O4 (363.2158)

(1S,5R)-N-(3-methoxyphenyl)-7-[4-[(E)-prop-1-enyl]phenyl]-3,6-diazabicyclo[3.1.1]heptane-6-carboxamide

C22H25N3O2 (363.1947)

(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]-3-phenylpropanoic acid

C19H29N3O4 (363.2158)

Asp-Met-Val

C14H25N3O6S (363.1464)

Lys-Cys-Asn

C13H25N5O5S (363.1576)

Asp-Val-Met

C14H25N3O6S (363.1464)

Cys-Glu-Leu

C14H25N3O6S (363.1464)

Glu-Cys-Ile

C14H25N3O6S (363.1464)

Glu-Leu-Cys

C14H25N3O6S (363.1464)

Ile-Cys-Glu

C14H25N3O6S (363.1464)

Ile-Glu-Cys

C14H25N3O6S (363.1464)

Ile-Thr-Met

C15H29N3O5S (363.1828)

Leu-Glu-Cys

C14H25N3O6S (363.1464)

Met-Ile-Thr

C15H29N3O5S (363.1828)

Phe-Thr-Pro

C18H25N3O5 (363.1794)

Pro-Phe-Thr

C18H25N3O5 (363.1794)

Thr-Ile-Met

C15H29N3O5S (363.1828)

Thr-Met-Leu

C15H29N3O5S (363.1828)

Val-Met-Asp

C14H25N3O6S (363.1464)

Met-Thr-Leu

C15H29N3O5S (363.1828)

Lys-Asn-Cys

C13H25N5O5S (363.1576)

Phe-Pro-Thr

C18H25N3O5 (363.1794)

Asn-Cys-Lys

C13H25N5O5S (363.1576)

Asn-Lys-Cys

C13H25N5O5S (363.1576)

Cys-Asn-Lys

C13H25N5O5S (363.1576)

Cys-Glu-Ile

C14H25N3O6S (363.1464)

Cys-Ile-Glu

C14H25N3O6S (363.1464)

Cys-Leu-Glu

C14H25N3O6S (363.1464)

Cys-Lys-Asn

C13H25N5O5S (363.1576)

Glu-Cys-Leu

C14H25N3O6S (363.1464)

Glu-Ile-Cys

C14H25N3O6S (363.1464)

His-His-Ala

C15H21N7O4 (363.1655)

Ile-Met-Thr

C15H29N3O5S (363.1828)

Leu-Cys-Glu

C14H25N3O6S (363.1464)

Leu-Met-Thr

C15H29N3O5S (363.1828)

Leu-Thr-Met

C15H29N3O5S (363.1828)

Met-Leu-Thr

C15H29N3O5S (363.1828)

Met-Thr-Ile

C15H29N3O5S (363.1828)

Phe-Val-Val

C19H29N3O4 (363.2158)

Pro-Thr-Phe

C18H25N3O5 (363.1794)

Thr-Leu-Met

C15H29N3O5S (363.1828)

Thr-Met-Ile

C15H29N3O5S (363.1828)

Val-Asp-Met

C14H25N3O6S (363.1464)

L-arginyl-L-glutamic acid monoacetate

C13H25N5O7 (363.1754)

(2R,3S,4S,5R,6S)-2-ethyl-6-{6-[(3-methylbut-2-en-1-yl)amino]-9H-purin-9-yl}oxane-3,4,5-triol

C17H25N5O4 (363.1906)

3-(4-Morpholinyl)-2-phenyl-1-[4-(trifluoromethyl)phenyl]-1-propanone

C20H20F3NO2 (363.1446)

Heptanone-etheno dC

C18H25N3O5 (363.1794)

HexCer 8:1;2O/2:0

C16H29NO8 (363.1893)

N-Acetylalanylphenylalanylalanine methyl ester

C18H25N3O5 (363.1794)

(2S)-2-[4-(1-Ethoxyethoxy)-1-oxobutyl]pyrrolidine-1-carboxylic acid benzyl ester

C20H29NO5 (363.2046)

6-Methoxy-9-[2-(6-methylpyridin-3-yl)ethyl]-3-propyl-1,2,3,4-tetrahydro-gamma-carboline

C23H29N3O (363.2311)

[2-[Acetyl(methyl)amino]-5-acetyloxy-1-deuterio-3,4,6-trimethoxyhexyl] acetate

C16H29NO8 (363.1893)

stemocurtisine N-oxide

C19H25NO6 (363.1682)

A natural product found in Stemona curtisii.

4F-MDMB-BINACA

C19H26FN3O3 (363.1958)

Methyl (2S)-2-[1-(5-fluoropentyl)-1H-indazole-3-carboxamido]-3-methylbutanoate

C19H26FN3O3 (363.1958)

Val-Val-Phe

C19H29N3O4 (363.2158)

HexCer 8:1;O2/2:0

C16H29NO8 (363.1893)

ST 18:2;O3;Gly

C20H29NO5 (363.2046)

E1231

C21H21N3O3 (363.1583)

E1231 is an orally active activator of Sirtuin 1 (SIRT1) (EC50=0.83 μM), to modulate cholesterol and lipid metabolism. E1231 interactes with SIRT1 (KD=9.61 μM) and deacetylated liver X receptor-alpha (LXRα), and increases ATP-binding cassette transporter A1 (ABCA1) expression. E1231 also reduces atherosclerotic plaque development in ApoE-/- mice model. E1231 can be used for research in cholesterol and lipid disorder-related diseases[1]. E1231 is an orally active activator of Sirtuin 1 (SIRT1) (EC50=0.83 μM), to modulate cholesterol and lipid metabolism. E1231 interactes with SIRT1 (KD=9.61 μM) and deacetylated liver X receptor-alpha (LXRα), and increases ATP-binding cassette transporter A1 (ABCA1) expression. E1231 also reduces atherosclerotic plaque development in ApoE-/- mice model. E1231 can be used for research in cholesterol and lipid disorder-related diseases[1].

ZINC13466751

C20H21N5O2 (363.1695)

ZINC13466751 is a potent inhibitor of HIF-1α/von Hippel-Lindau interaction with an IC50 of 2.0 μM[1].

(2s)-1-{[(3r,3as,5ar,6r,9as,9bs)-6-hydroxy-5a,9-dimethyl-2-oxo-3h,3ah,4h,5h,6h,7h,9ah,9bh-naphtho[1,2-b]furan-3-yl]methyl}pyrrolidine-2-carboxylic acid

C20H29NO5 (363.2046)

(2s)-1-{[(3r,3as,5ar,6r,9as,9bs)-6-hydroxy-5a-methyl-9-methylidene-2-oxo-octahydro-3h-naphtho[1,2-b]furan-3-yl]methyl}pyrrolidine-2-carboxylic acid

C20H29NO5 (363.2046)

9-hydroxy-4-methoxy-10-methyl-11-(3-methylbut-2-en-1-yl)furo[3,2-b]acridin-5-one

C22H21NO4 (363.1471)

2-hydroxy-6'-(2-methylprop-1-en-1-yl)-1',7'-diazaspiro[indole-3,5'-tricyclo[7.3.0.0³,⁷]dodecan]-3'-ene-2',8'-dione

C21H21N3O3 (363.1583)

3-hydroxy-4,13b-dimethyl-1h,2h,3h,4ah,5h,6h,8h-naphtho[2,1-b]carbazole-4-carboxylic acid

C23H25NO3 (363.1834)

(2s,4s,5s,6s)-4,5-dihydroxy-6-[3-(c-hydroxycarbonimidoylmethyl)-4-methoxyindol-1-yl]oxane-2-carboximidic acid

C17H21N3O6 (363.143)

1-[(12s)-18-acetyl-13-methyl-5,7-dioxa-13-azapentacyclo[10.7.1.0²,¹⁰.0⁴,⁸.0¹⁶,²⁰]icosa-1(19),2,4(8),9,16(20),17-hexaen-19-yl]ethanone

C22H21NO4 (363.1471)

1,3-dihydroxy-2,4-bis(3-methylbut-2-en-1-yl)-10h-acridin-9-one

C23H25NO3 (363.1834)

(2s)-2-amino-5-{[(1r)-1-{[(1r)-1-carboxy-2-methylpropyl]-c-hydroxycarbonimidoyl}-2-sulfanylethyl]-c-hydroxycarbonimidoyl}pentanoic acid

C14H25N3O6S (363.1464)

3-benzyl-1-hydroxy-4-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}pyrrole-2,5-dione

C22H21NO4 (363.1471)

n-[(1r,5r,8r,9s)-1-(2,6-dimethylhepta-1,5-dien-1-yl)-9-hydroxy-3,6-dioxo-2-oxaspiro[4.5]decan-8-yl]ethanimidic acid

C20H29NO5 (363.2046)

(2s)-2-({hydroxy[(4s)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]methylidene}amino)-6-[(hydroxymethylidene)amino]hexanoic acid

C17H21N3O6 (363.143)

5-hydroxy-6-[(4-hydroxyphenyl)methyl]-3-(1h-indol-3-ylmethyl)-1-methyl-3,6-dihydropyrazin-2-one

C21H21N3O3 (363.1583)

11-(4-aminophenyl)-5,9-dihydroxy-4,6,8-trimethyl-11-oxoundec-2-enoic acid

C20H29NO5 (363.2046)

4-methoxy-23,24,25-triazatetracyclo[18.2.1.1²,⁵.1⁷,¹⁰]pentacosa-1(22),2(25),3,5,7,9,20-heptaene

C23H29N3O (363.2311)

methyl 4-hydroxy-3-methoxy-14-(2-methoxy-2-oxoethylidene)-9-azatetracyclo[7.5.0.0¹,⁶.0¹¹,¹³]tetradec-5-ene-13-carboxylate

C19H25NO6 (363.1682)

(1s,2r,5s,10s,13s)-10-hydroxy-1,2-dimethyl-6-oxa-22-azahexacyclo[11.10.0.0²,¹⁰.0⁵,⁹.0¹⁵,²³.0¹⁶,²¹]tricosa-8,15(23),16,18,20-pentaen-7-one

C23H25NO3 (363.1834)

n-[2,5-dihydroxy-3-(2-methylpropyl)-6,7,8,9-tetrahydro-3h-1,4-diazonin-6-yl]-2,3-dihydroxybenzenecarboximidic acid

C18H25N3O5 (363.1794)

1-[(2z)-3,7-dimethylocta-2,6-dien-1-yl]-2,8-dihydroxy-9h-carbazole-3-carbaldehyde

C23H25NO3 (363.1834)

1-epidechloroacutumine

C19H25NO6 (363.1682)

{"Ingredient_id": "HBIN002511","Ingredient_name": "1-epidechloroacutumine","Alias": "NA","Ingredient_formula": "C19H25NO6","Ingredient_Smile": "CN1CCC23C1(CCC24C(C(=CC4=O)OC)O)C(=C(C(=O)C3)OC)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6885","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

1-epi-dioncophylline b

C23H25NO3 (363.1834)

{"Ingredient_id": "HBIN002512","Ingredient_name": "1-epi-dioncophylline b","Alias": "NA","Ingredient_formula": "C23H25NO3","Ingredient_Smile": "CC1CC2=C(C(N1)C)C(=C(C=C2)C3=C(C4=C(C=C3)C=C(C=C4OC)C)O)O","Ingredient_weight": "363.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6895","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10498940","DrugBank_id": "NA"}

3,6,7-trimethoxyphenanthroindolizidine

C23H25NO3 (363.1834)

{"Ingredient_id": "HBIN007697","Ingredient_name": "3,6,7-trimethoxyphenanthroindolizidine","Alias": "NA","Ingredient_formula": "C23H25NO3","Ingredient_Smile": "COC1CCC2N1CC(C3=C2C=CC4=C3C(=CC5=CC=CC=C45)OC)OC","Ingredient_weight": "363.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21905","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "129664432","DrugBank_id": "NA"}